Relay Therapeutics, Inc.RLAYNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank29
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-235.46M
↓ 45% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-162.69M
Historical baseline
PeriodValueYoY Change
2025$-235.46M+5.5%
2024$-249.11M+17.1%
2023$-300.32M-30.9%
2022$-229.49M-208.4%
2021$-74.41M+27.4%
2020$-102.49M-55.0%
2019$-66.13M-49.8%
2018$-44.13M-